[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558728":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":56,"collaborators":18,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":18,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Aarhus University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention (delivering CIFeR)","EXPERIMENTAL","At the patient's first follow-up appointment after anti-cancer treatment, oncologists will, in addition to the usual follow-up procedure, deliver a brief psychological intervention (CIFeR)",[13],"Other: Clinician-led intervention to address fear of cancer recurrence (CIFeR)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control (treatment as usual)","NO_INTERVENTION","At the patients first follow-up appointment after anti-cancer treatment, oncologists will deliver treatment as usual (the usual follow-up procedure)",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Clinician-led intervention to address fear of cancer recurrence (CIFeR)","The intervention includes five components informed by theoretical models and existing interventions for FCR: 1) FCR normalization: reassurance that FCR is a common and normal phenomenon after treatment for cancer, 2) Providing prognostic information: asking patients whether they would like information about their risk of recurrence and, if yes,providing this information, 3) Providing education and take-home information on red-flag recurrence symptoms, 4) Brief advice on managing worry: distraction, meditation, mindfulness, reassurance, and links to online resources to manage FCR, and 5) referral to a psychologist if FCR is high (FCRI-SF \\>= 22), or if deemed helpful by the patient or clinician. Access will be provided to ConquerFear-Group delivered online by trained psychologists.",[9],[25],{"name":26,"affiliation":27,"role":28},"Robert Zachariae, Professsor","Aarhus University and Aarhus University Hospital, Denmark","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Eva Rames Nissen, PhD","CONTACT","+4587162674","enissen@oncology.au.dk",{"name":36,"role":32,"phone":18,"phoneExt":18,"email":37},"Louise Strøm, PhD","louisestroem@concology.au.dk",[39],{"facility":5,"status":40,"city":41,"state":18,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Aarhus","8200","Denmark","DK",{"type":46,"coordinates":47},"Point",[48,49],10.21076,56.15674,{"lat":49,"lon":48},[52],{"name":53,"role":32,"phone":54,"phoneExt":18,"email":55},"Birgitte Offersen, Professor","+4578454933","birgitte.offersen@auh.rm.dk",{"type":28,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Prof. Robert (Bobby) Zachariae","Professor","100558728","cifer---a-clinician-led-intervention-to-address-fear-of-cancer-recurrence-100558728",false,"NCT06554899","CIFeR - A Clinician-led Intervention to Address Fear of Cancer Recurrence","The Efficacy of a Brief Oncologist-delivered Intervention for Fear of Cancer Recurrence: A Cluster-randomized Controlled Trial","Inclusion Criteria:\n\n* Are ≥ 18 years old\n* Have completed their primary treatment, i.e., surgery, adjuvant chemotherapy, and\u002For radiotherapy, for breast, ovarian, prostate, or lung cancer at the participating departments between three weeks and three months previously.\n* Score \\>= 13 on the FCRI-SF\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":69,"type":70},300,"ESTIMATED","INTERVENTIONAL",[73],"NA","The investigators will test a novel Clinician-led Intervention to address Fear of cancer Recurrence in cancer survivors (CIFeR), by 1) adapting the original Australian intervention manual to the Danish oncology context (CIFeR-DK), and 2) developing a brief e-learning program to train oncologists. The investigators will then 3) compare CIFeR-DK with an active control condition in a cluster-randomized controlled trial with 24 oncologists (the cluster unit) treating a minimum of 300 patients with breast, ovarian, lung and prostate cancer at Danish Oncology Departments at four hospitals in Aarhus, Vejle, Aalborg, and Copenhagen, and 4) explore fidelity, acceptability, feasibility, and perceived barriers and facilitators to use the intervention in routine follow-up care.",[76],"Fear of Cancer Recurrence","2024-08-19",{"date":79,"type":80},"2024-08-21","ACTUAL",{"date":82,"type":80},"2024-06-14",{"date":84,"type":70},"2026-06-01",{"name":5,"class":6},1]